secwatch.observer — SEC 8-K summary
======================================

Issuer:     C4 Therapeutics, Inc. (CCCC)
CIK:        0001662579
Form:       8-K
Filed at:   2022-06-17T23:59:59+00:00
Accession:  0001564590-22-023555
Event type: leadership
Sentiment:  neutral
Materiality: 0.25
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Director Alain J. Cohen withdraws; board commits to gender-diverse appointments
-------------------------------------------------------------------------------

- Alain J. Cohen withdrew as director nominee for re-election at 2022 annual meeting; no disagreements with company.
- Cohen will cease serving as director and compensation committee member on June 22, 2022.
- Board will not nominate a replacement director for the 2022 annual meeting.
- Board committed to appoint two gender-diverse directors by the next annual meeting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1662579/000156459022023555/0001564590-22-023555-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1662579/000156459022023555/cccc-8k_20220615.htm
  HTML page:      https://secwatch.observer/filing/0001564590-22-023555

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer